Arsenic trioxide in the treatment of haematological malignancies

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.6, 2004-11, pp. : 589-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo Martinelli Giovanni Baccarani Michele

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide for the treatment of myelodysplastic syndromes

By Vey Norbert

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 613-621

Informa Healthcare

Access to resources Recommend Favorite

Nucleoside analogues in the treatment of haematological malignancies

By Johnson Stephen A

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 929-943

Informa Healthcare

Access to resources Recommend Favorite

Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 397-405

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly

Current Pharmaceutical Design, Vol. 16, Iss. 26, 2010-09 ,pp. : 2872-2879

Bentham Science Publishers

Access to resources Recommend Favorite